ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ACOR Acorda Therapeutics Inc

0.661
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Acorda Therapeutics Inc ACOR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.661 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.661
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/4/202416:03BWAcorda Therapeutics Announces Delisting from Nasdaq
03/4/202416:30BWAcorda Therapeutics Announces Nasdaq Delisting Notification
01/4/202417:35BWAcorda Therapeutics and Merz Announce Signing of “Stalking..
01/4/202415:01BWAcorda Cancels Q4 and Year End 2023 Earnings Conference Call..
25/3/202415:01BWAcorda Fourth Quarter/Year End 2023 Update:..
11/1/202407:33EDGAR2Form 8-K - Current report
11/1/202407:01BWAcorda Therapeutics to Regain Global Commercialization..
01/12/202315:30EDGAR2Form 8-K - Current report
13/11/202315:16EDGAR2Form 8-K - Current report
13/11/202315:01BWAcorda Therapeutics Reports Third Quarter 2023 Financial..
06/11/202315:01BWAcorda Third Quarter 2023 Update: Webcast/Conference Call..
06/11/202307:00BWAcorda Therapeutics Announces Biopas Laboratories Submission..
08/8/202315:12EDGAR2Form 8-K - Current report
08/8/202315:01BWAcorda Therapeutics Reports Second Quarter 2023 Financial..
02/8/202307:00BWAcorda Therapeutics Announces Launch of New INBRIJA®..
01/8/202307:00BWAcorda Second Quarter 2023 Update: Webcast/Conference Call..
28/6/202316:08BWTom Burns Elected to the Acorda Therapeutics Board of..
26/6/202307:23BWAcorda Therapeutics Regains Compliance with Nasdaq Minimum..
26/6/202307:00BWAcorda Therapeutics Regains Compliance with Nadaq Minimum..
02/6/202315:01BWAcorda Therapeutics Announces Completion of 1-for-20 Reverse..
31/5/202315:01BWAcorda Therapeutics to Conduct 1-for-20 Reverse Stock Split
30/5/202307:00BWAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual..
11/5/202315:01BWAcorda Therapeutics Reports First Quarter 2023 Financial..
10/5/202306:00BWAcorda Therapeutics to Make June 2023 $6.2 Million Interest..
08/5/202306:00BWAcorda Therapeutics and Chance Pharmaceuticals Announce..
04/5/202308:41BWAcorda First Quarter 2023 Update: Webcast/Conference Call..

Su Consulta Reciente

Delayed Upgrade Clock